CapsoVision CV
NASDAQ CV
$6.02 +0.11 (+1.86%)
At close: Aug 21, 2026 · 4:00 PM EDT

CapsoVision (CV) Depreciation & Amortization (CF) (2024 - 2026)

CapsoVision (CV) posted Depreciation & Amortization (CF) of $55000.0 for Q4 2025, up 1.85% sequentially from $54000.0 in Q3 2025, and up 7.84% YoY from $51000.0 in Q4 2024.

CapsoVision (CV) Depreciation & Amortization (CF) (2024 - 2026) Analysis & Trends

CapsoVision has reported Depreciation & Amortization (CF) for 2 years, with the latest figure at $55000.0 in Q4 2025.

  • Quarterly Depreciation & Amortization (CF) rose 7.84% year-over-year to $55000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $215000.0 (changed N/A YoY) and the FY2025 annual result came in at $216000.0, up 4.85% from the prior year.
  • Depreciation & Amortization (CF) rose to $55000.0 in Q4 2025 per CV's latest filing, from $54000.0 in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $55000.0 in Q2 2025 and troughed at $51000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn 716.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn 355.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn 42.70 Mn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn 68.20 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 750.89 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn 123.80 Mn
10 CapsoVision 299.87 Mn 290.80 Mn 1.87 Mn 58,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 58,000.00
Jun 30, 2026 58,000.00
Dec 31, 2025 55,000.00
Dec 31, 2025 55,000.00
Sep 30, 2025 54,000.00
Sep 30, 2025 54,000.00
Jun 30, 2025 55,000.00
Jun 30, 2025 55,000.00
Dec 31, 2024 51,000.00
Dec 31, 2024 51,000.00
Sep 30, 2024 52,000.00
Sep 30, 2024 52,000.00
Jun 30, 2024 52,000.00
Jun 30, 2024 52,000.00